Furiex Pharmaceuticals (FURX) Narrows Q1 Loss
Tweet
Share
E-mailGet Alerts FURX Hot Sheet
Join SI Premium – FREE
Furiex Pharmaceuticals (Nasdaq: FURX) reported Q1 loss of $0.87, versus ($1.45) last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Octave Intelligence plc (OCTV) Tops Q2 EPS by 4c ; Offers Guidance
- Riskified Ltd. (RSKD) Reports In-Line Q2 EPS ; Offers Guidance
- SDCH (SDCH) Reports Q2 Loss of $0.03
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
